Verenium has access to a robust intellectual property portfolio with patents covering key technologies in the discovery, optimization, production and use of novel protein-based products. In addition, we own numerous composition of matter patents covering our novel enzyme products and product candidates. Verenium currently owns over 150 issued patents and over 310 patents pending (as of August 2010). Verenium continues to develop new products and technologies. Verenium offers several services including discovery, optimization, and production of protein-based products, covered in part under the following patents:

Selected Patents
5,939,250 Production of enzymes having desired activities by mutagenesis
5,958,672 Protein activity screening of clones having DNA from uncultivated microorganisms
6,001,574 Production and use of normalized DNA libraries
6,168,919 Screening methods for enzymes and enzyme kits
6,171,820 Saturation mutagenesis in directed evolution
6,280,926 Gene expression library produced from DNA from uncultivated microorganisms and methods for making the same
6,344,328 Method for screening for enzyme activity
6,455,254 Sequence based screening
6,537,776 Synthetic ligation reassembly in directed evolution
6,632,600 Altered thermostability of enzymes